HAMMER TECHNOLOGY HOLDINGS CORP. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HAMMER TECHNOLOGY HOLDINGS CORP. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $0 | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | $420 | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | $3.26M | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | $2.60M | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | $2.20M | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | $1.78M | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $2.18M | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | $0 | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | $87.7K | Nov 20, 2018 |
| FY2016 | Jul 31, 2016 | $0 | Mar 22, 2017 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jul 31, 2017 | $87.7K | Nov 8, 2017 |
| FY2017 | Jul 31, 2016 | $0 | Nov 8, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | $881.3K | Feb 4, 2025 |
| FY2024 | Jul 31, 2023 | $830.2K | Feb 4, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($2.80M) | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | ($1.23M) | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | ($2.58M) | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | ($4.78M) | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | $2.47M | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | ($924.4K) | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | ($7.80M) | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | ($5.52M) | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | ($6.04M) | Nov 20, 2018 |
| FY2017 | Jul 31, 2016 | ($2.19M) | Nov 8, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($3.41M) | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | ($1.40M) | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | ($1.25M) | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | ($1.02M) | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | ($119.0K) | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | ($277.7K) | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | ($137.5K) | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | $0 | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | ($5.69M) | Nov 20, 2018 |
| FY2017 | Jul 31, 2016 | ($2.01M) | Nov 8, 2017 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $842.6K | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | $728.7K | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | $1.36M | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | $1.16M | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | $694.4K | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | $857.4K | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $866.7K | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | $0 | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | $4.88M | Nov 20, 2018 |
| FY2017 | Jul 31, 2016 | $1.70M | Nov 8, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | ($760.2K) | Feb 4, 2025 |
| FY2023 | Jul 31, 2023 | ($636.7K) | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | ($452.0K) | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | ($78.4K) | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | $150.7K | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | ($435.3K) | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | $0 | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | ($4.84M) | Nov 20, 2018 |
| FY2017 | Jul 31, 2016 | ($449.5K) | Nov 8, 2017 |
| FY2016 | Jul 31, 2015 | ($444.2K) | Mar 22, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jul 31, 2024 | $19.7K | Feb 4, 2025 |
| FY2023 | Jul 31, 2023 | $12.7K | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | $46.9K | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | $75.5K | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | $52.0K | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $95.8K | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | $0 | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | $734.3K | Nov 20, 2018 |
| FY2017 | Jul 31, 2016 | $3.83M | Nov 8, 2017 |
| FY2016 | Jul 31, 2015 | ($54.6K) | Mar 22, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $235.5K | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | $3.04M | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | $3.74M | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | $6.14M | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | $4.90M | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | $5.14M | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $5.48M | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | $4.66M | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | $5.84M | Nov 20, 2018 |
| FY2017 | Jul 31, 2016 | $6.84M | Nov 8, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $963.6K | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | $4.00M | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | $3.67M | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | $3.74M | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | $2.42M | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | $10.48M | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | $10.21M | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | $4.17M | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | $3.83M | Nov 20, 2018 |
| FY2017 | Jul 31, 2016 | $4.00M | Nov 8, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($728.1K) | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | ($961.3K) | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | $71.2K | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | $2.40M | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | $2.48M | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | ($5.34M) | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | ($4.73M) | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | $486.8K | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | $2.01M | Nov 20, 2018 |
| FY2017 | Jul 31, 2016 | $2.84M | Nov 8, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | ($31.83M) | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | ($29.03M) | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | ($27.80M) | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | ($25.22M) | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | ($20.44M) | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | ($22.91M) | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | ($21.99M) | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | ($14.19M) | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | ($8.68M) | Nov 20, 2018 |
| FY2017 | Jul 31, 2016 | ($2.64M) | Nov 8, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | $18.1K | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | $0 | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | $66.7K | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | $482.9K | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | $77.6K | Feb 8, 2023 |
| FY2022 | Jul 31, 2020 | $73.9K | Feb 8, 2023 |
| FY2021 | Jul 31, 2019 | $87.8K | Oct 29, 2021 |
| FY2020 | Jul 31, 2018 | $528.4K | Dec 8, 2020 |
| FY2019 | Jul 31, 2017 | $528.4K | Nov 20, 2019 |
| FY2018 | Jul 31, 2016 | $563.8K | Nov 20, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 0 | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | 0 | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | 0 | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | 0 | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | 0 | Feb 8, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 0 | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | 0 | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | 0 | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | 0 | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | 0 | Feb 8, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jul 31, 2025 | 69.06M | Oct 29, 2025 |
| FY2025 | Jul 31, 2024 | 61.40M | Oct 29, 2025 |
| FY2023 | Jul 31, 2023 | 60.45M | Feb 19, 2025 |
| FY2023 | Jul 31, 2022 | 59.81M | Feb 19, 2025 |
| FY2022 | Jul 31, 2021 | 60.85M | Feb 8, 2023 |
| FY2021 | Jul 31, 2020 | 52.88M | Oct 29, 2021 |
| FY2020 | Jul 31, 2019 | 45.09M | Dec 8, 2020 |
| FY2019 | Jul 31, 2018 | 52.95M | Nov 20, 2019 |
| FY2018 | Jul 31, 2017 | 51.96M | Nov 20, 2018 |
| FY2017 | Jul 31, 2016 | 60.50M | Nov 8, 2017 |